Unlike thymomas, thymic carcinomas rarely express autoimmune-related antigens (25, 26) but frequently exhibit moderate PD-L1 expression (27, 28) and tumor-infiltrating lymphocytes (TILs), suggesting a plausible biological basis for the application of ICIs (21, 22). Here, CD274 is linked to thymoma.